Evidence map›Paper›PMID 24937930›Full record

Trial reportMedical archives (Sarajevo, Bosnia and Herzegovina)2014

Use of serum levels of proinflammatory cytokine IL-1alpha in chronic hepatitis B.

Zora Vukobrat-Bijedic, Amila Mehmedovic, Amir Redzepovic, Bisera Gogov

Abstract readClinical TrialComparative Study
In one paragraph

Trial report in Medical archives (Sarajevo, Bosnia and Herzegovina), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zora Vukobrat-Bijedic
Amila Mehmedovic
Amir Redzepovic
Bisera Gogov
Academy of Medical Sciences of Bosnia and Herzegovina · BAUniversity of Sarajevo · BA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe reasons for the chronic viral persistence of hepatitis B virus infection (HBV) are unknown, but are probably related to host immune factors. Cytokines play a significant role in immune defense. Interleukin-1 (IL-1) is a proinflammatory cytokine and some studies have demonstrated that IL-1 production was impaired in patients with chronic infections of hepatitis B virus, implying that IL-1 may play a role in viral clearance, progression of fibrosis and in malignant potential of HBV. In this study, along with routine laboratory tests, has been performed the analysis of serum levels of proinflammatory cytokine IL-1alpha in order of better understanding and monitoring of chronic hepatitis B.

objectiveThe aim of this study was to analyze the usefulness of laboratory tests, which are routinely used in the assessment of liver disease with specified immunological parameters in patients with chronic hepatitis B. PATIENTS AND

methodsTotal of 60 subjects was divided into two groups: HBV- PCR positive and negative group. The control group of 30 healthy participants was included. Apart from standard laboratory tests, the analysis included serum levels of cytokine IL-1alpha. RESULTS AND DISCUSSION: IL-1alpha had the highest mean concentration in group 1-viral hepatitis C, with PCR positive test (5.73 pg/ml), and then in group 2-viral hepatitis B, PCR negative test (5.39 pg/ml). ANOVA test proves that IL-1alpha in the healthy group (3) was different from other groups as follows: in relation to group 1 statistical significance level was p <0.001 (F = 32 75 5); in relation to group 2 was also statistically significant at p < 0.001 (F = 182 361); Cytokine IL-1 was statistically analyzed separately and compared by group 1 and 2 using Student t-test for independent samples. Statistical significance was observed at p = 0.026. IL-1alpha was positively correlated with the duration of the illness (p < 0.01) and with serum ALT activity (p < 0.01) and serum AST activity (p < 0.01). Using multivariate analysis model "Factor Analysis", was made significant stratification predictive parameters in relation to the cytokine IL-1alpha, stratified significance is indicated as follows: 1. Age, 2. history of receiving transfusions, 3. ALT, 4. AST, 5. MELD score (negative), 6. Child-Pugh score (Negative).

conclusionIL-1alpha was significantly elevated in inflammatory conditions of pronounced activity (PCR positive hepatitis). IL-1alpha may have important role as marker of both inflammation and hepatic injury, particularly in the course of hepatitis B. Results suggest that inflammatory and immune parameters, analyzed together can significantly contribute to the understanding and predicting of chronic liver damage. IL-1 can be used as important parameter of inflammatory activity and fibrosis evaluation and eventually prediction of malignant transformation in chronic liver damage.

Indexed as

AdolescentAdultAgedAged, 80 and overBiomarkersCase-Control StudiesDisease ProgressionFemaleHepatitis B, ChronicHumansInterleukin-1alphaMaleMiddle AgedPolymerase Chain ReactionBiomarkersInterleukin-1alpha

Identifiers

PMID24937930
PMCPMC4272509
OpenAlexW1916362479

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.